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ABSTRACT The unfolding and refolding of apohorseradish peroxidase, as a function of guanidinium chloride concentration,
were monitored by the intrinsic fluorescence intensity, polarization, and lifetime of the single tryptophan residue. The
unfolding was reversible and characterized by at least three distinct stages—the intensity and lifetime data, for example, were
both characterized by an initial increase followed by a decrease and then a plateau region. The lifetime data, in the absence
and presence of guanidinium chloride, were heterogeneous and fit best to a model consisting of a major Gaussian distribution
component and a minor, short discrete component. The observed increase in intensity in the initial stage of the unfolding
process is attributed to the conversion of this short component into the longer, distributed component as the guanidinium
chloride concentration increases. Our results clarify and amplify previous studies on the unfolding of apohorseradish
peroxidase by guanidinium chloride.
INTRODUCTION
Horseradish peroxidase (donor:hydrogen-peroxidase oxi-
doreductase, EC 1.11.1.7) (HRP) is a member of the im-
portant group of plant peroxidases that catalyze the oxida-
tion and peroxidation of a variety of organic and inorganic
compounds. A number of acidic, neutral, and basic isoen-
zymes of HRP have been identified and classified (Shannon
et al., 1966; Paul and Stigbrand, 1970; Delincee and Rado-
lla, 1970; Bartonek-Roxå et al., 1991). HRP-C is a mono-
meric glycoprotein of molecular weight 44,000 with eight
N-linked carbohydrate chains and one noncovalently bound
hemin moiety (Clarke and Shannon, 1976; Welinder, 1979,
1985).
The unfolding and refolding of HRP, with and without
the heme moiety, are of general interest to those studying
protein denaturation and renaturation and are of specific
interest to those interested in the expression of recombinant
HRP (Smith et al., 1990; Hartman and Ortiz de Montellano,
1992; Bartonek-Roxå and Eriksson, 1994; Moosavi-Mova-
jedi and Nazari, 1995). Fluorescence spectroscopy has been
widely applied to the study of protein folding (see, for
example, James et al., 1992; Eftink, 1994; Watanabe et al.,
1996; Jiskoot et al., 1995). In the case of HRP, both intrinsic
and extrinsic fluorescent probes have been utilized for this
purpose. Extrinsic probes utilized include 1-anilino-8-naph-
thalene sulfonate (ANS), 4,4-bis(1-anilino-8-naphthalene
sulfonate (bis-ANS), 2-p-toluidiny-6-naphthalene sulfonate
(TNS), and protoporphyrin IX (PPIX), which bind to and
monitor the heme binding site (Ugarova et al., 1981; Jullian
et al., 1989; Vargas et al., 1991; Brunet et al., 1994). HRP’s
single tryptophan residue (W117) also serves as an intrinsic
probe that can monitor another region of the protein. Al-
though the x-ray structure of HRP is not yet available,
fluorescence energy transfer studies indicate that the tryp-
tophan residue is between 12 and 18 Å from the heme
binding site (Brunet et al., 1983; Ohlsson et al., 1986; Pappa
and Cass, 1993; Das and Mazumdar, 1995). Hence, by
monitoring the intrinsic tryptophan fluorescence as well as
the fluorescence of probes associated with the heme binding
site one can, in principle, follow the effects of denaturants
on two distinct regions of the protein.
Recently, Pappa and Cass (1993), motivated by an inter-
est in understanding the refolding of recombinant protein
isolated from inclusion bodies, described fluorescence and
circular dichroism (CD) measurements on the guanidinium
chloride-induced unfolding and refolding of both holo- and
apoHRP. They found that their fluorescence intensity re-
sults on apoHRP could be fit to a two-stage transition,
whereas their CD results (based on both 278 nm and 222 nm
observations) suggested a more complex unfolding pattern.
They also suggested that PPIX associated with apoHRP
exhibited considerable local motion, indicating a loose as-
sociation with the heme binding site, and that it did not
stabilize the protein structure as well as hemin. Our previous
results on dynamic aspects of apoHRP-PPIX and our recent
studies on the guanidinium chloride-induced unfolding of
apoHRP prompted us to reevaluate some of the conclusions
of Pappa and Cass. To this end we utilized both steady-state
(including polarization) and time-resolved fluorescence
measurements on the intrinsic fluorescence of apoHRP. Our
results led us to conclude that there are, in fact, at least two
spectroscopically distinct forms of apoHRP in the absence
of GuHCl and that the distinction begins to disappear im-
mediately upon the addition of denaturant, well before the
overall collapse of the native structure, which occurs at
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higher denaturant concentrations. This conclusion, based on
lifetime results, cannot be reached by the observations of
steady-state intensities carried out by Pappa and Cass.
MATERIAL AND METHODS
Preparation of ApoHRP
Boehringer Mannheim EL grade HRP, which contains isoenzyme C as the
major component, was utilized without further purification. The apoHRP
was prepared by removing the heme group according to Teale’s method
(Teale, 1959) of cold acid and butanone extraction followed by exhaustive
dialysis at 4°C against 0.1 M sodium phosphate buffer at pH 7.4. The
concentration of apoHRP was determined by absorption spectrophotome-
try, using a molar extinction coefficient of 20,000 M1 cm1 at 280 nm
(Tamura et al., 1972).
Unfolding/refolding protocols
For the denaturation experiments guanidinium chloride from an 8.0 M
stock solution was used, and appropriate protein aliquots from a protein
stock solution were added to the desired concentration of denaturant such
that the final protein concentration was 5.0  106 M. Spectral measure-
ments were taken 24 h after introduction of the denaturant. The renatur-
ation experiments were performed by dissolving the protein in 8.0 M
guanidinium chloride, followed by a 24-h incubation period, readjustment
of the denaturant concentration, and then another 24-h incubation period
before the fluorescence measurements were performed. Because reducing
reagents are not added during unfolding or refolding experiments, the four
disulfide bonds of apoHRP remain intact.
Steady-state fluorescence
Uncorrected fluorescence spectra were obtained with a SPEX Fluorolog
photon counting spectrofluorimeter updated with ISS (ISS, Champaign, IL)
acquisition electronics and software. The total fluorescence intensity and
the polarization measurements were obtained on a Greg 200 spectroflu-
orometer (ISS). Spectral bandwidths of 2 nm were used for all measure-
ments, and all signals were corrected for buffer blanks. For the total
intensity measurements on the intrinsic fluorescence, the proteins were
excited at 295 nm and emission at wavelengths greater than 305 nm was
viewed through a Schott WG 315 cut-on filter. The polarization measure-
ments were performed using 300-nm excitation and viewing emission at
wavelengths greater than 325 nm through a Schott WG 335 cut-on filter.
The total fluorescence intensity, obtained upon excitation with parallel
polarized light, was obtained as IT  I  2I, where I and I are the
intensities observed through polarizers oriented, respectively, parallel and
perpendicular to the laboratory axis.
Time-resolved fluorescence
Time-resolved measurements were obtained using a laser-based instrument
at the Laboratory for Fluorescence Dynamics (LFD) at the University of
Illinois at Urbana-Champaign. In this laser-based instrument, the frequency
modulation of the excitation source is realized using the harmonic content
approach (Gratton et al., 1984; Alcala et al., 1985). The exciting light was
from a Coherent Nd:YAG mode-locked laser pumping a rhodamine dye
laser. The dye laser was tuned to 590 nm, which was then frequency
doubled to 295 nm. Emission was observed through a Schott WG320 filter
to isolate the emission of tryptophan and to block scattered light. The
exciting light was polarized parallel to the vertical laboratory axis, and the
emission was viewed through a polarizer oriented at 55° to eliminate
polarization effects on the lifetime measurements (Spencer and Weber,
1970). The reference fluorophore used was p-terphenyl in ethanol with a
lifetime of 1.05 ns. Phase and modulation values for the lifetime data were
obtained as previously described (Spencer and Weber, 1969; Jameson et
al., 1984; Jameson and Hazlett, 1991). The lifetime data were analyzed
either by assuming a sum of discrete exponentials (Jameson et al., 1984) or
by using continuous distribution models that assumed either Lorentzian or
Gaussian distributions (Alcala et al., 1987a,b,c).
RESULTS
Intensity and spectral measurements
Fig. 1 shows the unfolding and the refolding of apoHRP in
the presence of varying concentrations of guanidinium chlo-
ride as monitored by the total fluorescence intensity upon
FIGURE 1 Total fluorescence intensity for apoHRP as
a function of guanidinium chloride concentration at 20°C:
unfolding (F) and refolding (E).
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295-nm excitation. The unfolding pathway, monitored in
this fashion, exhibits an increase in the emission intensity
reaching a maximum at 0.6 M guanidinium chloride fol-
lowed by a decrease, and then a stabilization at an intensity
slightly higher than the initial value. The unfolding and
folding curves follow nearly the same path, indicative of a
reversible process, although the maximum intensity ob-
served on the folding pathway (near 0.6 M) is less than that
observed on the unfolding pathway. Fig. 2 shows the effect
of guanidinium chloride concentration on the emission
maximum of apoHRP. The maximum in the absence of
denaturant is 343 nm and increases immediately upon the
addition of guanidinium chloride, with a small plateau ap-
pearing near 0.6 M, finally leveling off at 356 nm near 4 M
denaturant.
Polarization measurements
The effects of guanidinium chloride on the polarization of
apoHRP are shown in Fig. 2. Excitation at 300 nm was used
for these unfolding and refolding polarization experiments,
because this wavelength does not excite tyrosine residues
and avoids the complication of tyrosine-to-tryptophan en-
ergy transfer. The unfolding pathway, monitored in this
fashion, shows a generally monotonic decrease in polariza-
tion as a function of denaturant concentration, with slight
but reproducible changes in slopes at 0.6 M, 2 M, and
4 M guanidinium chloride. The polarization values along
the refolding pathway closely follow those of the unfolding
pathway (data not shown). The excitation polarization spec-
trum for apoHRP in 0.1 M, pH 7.4 phosphate buffer at 20°C
is shown in the inset in Fig. 2. The data show the charac-
teristic features associated with proteins containing tyrosine
and tryptophan residues (Weber, 1960). The ratio of the
polarizations observed upon excitation at 300 nm relative to
270 nm is high (1.92), indicative of significant tyrosine-to-
tryptophan energy transfer (Weber, 1960). Tryptophan in a
rigid medium, for example, exhibits a 300/270 ratio near
1.45.
Lifetime measurements
The lifetime data for apoHRP were indicative, in all cases,
of heterogeneous decay, i.e., in the presence or absence of
denaturant, phase and modulation data could not be fit to a
single-exponential model. Table 1 shows, for example, fits
of the lifetime data for apoHRP at 0.5 M guanidinium
chloride, to single, double, and triple discrete exponential
decays, as well as to Lorentzian and Gaussian distribution
models. The data were well fit to a predominant Gaussian
component and a small fraction of a discrete component
(0.35 ns). Fig. 3 shows the Gaussian distributions for apo-
HRP in 0 M, 0.5 M, and 7.6 M guanidinium chloride. Fig.
4 shows the variation of the center and the width of the
Gaussian distributions and the fractional contribution of the
discrete component as a function of guanidinium chloride
concentration. One notes that the center value of the distri-
bution increases immediately upon the addition of the de-
naturant and goes from 3.3 ns at 0 M to 3.9 ns near 0.6 M
guanidinium chloride. Concomitantly, the fraction attrib-
uted to the short, discrete component decreases steadily as
the denaturant concentration increases (Fig. 4, inset) and
disappears near 0.5 M denaturant (these data were analyzed
by global analysis, wherein the lifetime of the discrete
component was linked throughout the data sets but all other
parameters were free to vary). Fig. 4 also shows the center
values for the distributions obtained for apoHRP upon di-
lution of the denaturant.
FIGURE 2 ApoHRP emission maximum (F) and po-
larization (f) as a function of guanidinium chloride
concentration at 20°C. Inset shows the excitation polar-
ization spectrum for apoHRP.
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DISCUSSION
The fluorescence intensity versus denaturant curves we ob-
tained (Fig. 1) were roughly similar to those of Pappa and
Cass (1993) but differed in the ratio of the intensities
corresponding to the maximum value (at 0.6 M guani-
dinium chloride) and the value observed at the maximum
denaturant concentration. Specifically, the ratio we ob-
served for these values was nearly 2, whereas that obtained
by Pappa and Cass (1993) was close to 1.2. Pappa and Cass
also reported that the initial increase in intensity upon the
addition of guanidinium chloride exhibited a sigmoidal
shape, which they stated was characteristic of a simple
two-state transition. Our results, however, did not show
such sigmoidal behavior. These differences are due to the
methodology utilized by Pappa and Cass. Specifically,
Pappa and Cass observed the emission intensity at 350 nm,
upon 290-nm excitation, as a function of denaturant con-
centration. In the case of HRP, this approach is problematic
for two reasons: 1) 290 nm will excite some tyrosine fluo-
rescence (which will, according to our excitation polariza-
tion results (vide supra), transfer energy to the tryptophan
moiety) and, more importantly, 2) the emission maximum
changes upon the addition of denaturant, and consequently
observation at a fixed emission wavelength will immedi-
ately lead to apparent shifts in intensity not related to the
actual quantum yield. For these reasons we employed
295-nm excitation to minimize excitation of tyrosine resi-
dues, and, more importantly, we observed the total fluores-
cence intensity through a cut-on filter by exciting with
parallel light and determining the total intensity function,
IT  I  2I, where I and I are the intensities observed
through polarizers oriented, respectively, parallel and per-
pendicular to the laboratory axis. This method has the
additional advantage that it avoids systematic errors in
observed intensities, which can arise in two ways when
there are changes in polarization: 1) preferential response of
the monochromator/detector system to one plane of polar-
ization (Jameson, 1984) and 2) the intrinsic bias introduced
by a right angle observation geometry (Spencer and Weber,
1970). We note that this approach works well when the
quantum yield of the system changes; however, in some
cases the more rigorous approach of collecting the com-
plete, corrected emission spectra associated with the parallel
and perpendicular components, followed by reconstruction
of the “total emission spectrum,” may be warranted. One
notes from the lifetime results (Fig. 4) that the maximum
lifetime value reached on the refolding path was the same as
that observed on the unfolding path, i.e., near 3.9 ns. These
results indicate that the decreased intensity observed on the
refolding path relative to the unfolding path (Fig. 1) may be
due to loss of some material, via aggregation for example,
which would affect intensity measurements but not lifetime
values.
The excited-state decays of a number of single trypto-
phan-containing proteins have been analyzed in terms of
continuous lifetime distribution models (Alcala et al.,
1987a,b,c; Gratton et al., 1992; Silva et al., 1994). Distri-
butional models are characterized by two parameters: the
center lifetime value and the width, i.e., full width at half-
maximum. The distributional approach to analyzing lifetime
data is based on the assumption that multiple protein con-
formational substates exist and that the dynamics of inter-
conversion between these states affects the observed life-
time (Silva et al., 1994). Our lifetime results demonstrate
that the excited-state kinetics exhibited by the tryptophan in
the apoHRP, in the absence or presence of the denaturant,
cannot be well fit, as judged by the reduced 2 value (Table
1), to one or two discrete decay components. However, the
lifetime data can be fit well to a single Gaussian distribu-
tional component plus a small fraction of a short, discrete
component, at denaturant concentrations below 0.5 M,
and to a single Gaussian distribution at denaturant concen-
trations above 0.5 M. These data also indicate that the
width of the lifetime distribution increased slightly as the
concentration of denaturant increased to 1.0 M guani-
dinium chloride, at which point the width decreased mark-
TABLE 1 Lifetime data for apoHRP in 0.5 M guanidinium chloride fit to various models
Discrete exponentials
1 f1 2 f2 3 f3 
2
3.08 1.00 — — — — 576
4.50 0.82 0.90 0.18 — — 11.7
5.53 0.59 2.10 0.36 0.41 0.05 0.41
Lorentzian
1 Width f1 2 f2 
2
3.90 1.54 0.93 0.68 0.07 2.70
Gaussian
1 Width f1 2 f2 
2
3.87 2.21 0.999 0.35 0.001 0.23
’s represent lifetime values in nanoseconds, f’s represent fractional intensity contributions, width refers to the full width at half-maximum, and 2
represents the reduced chi-squared value for the fit assuming errors of 0.2° and 0.004 for phase and modulation data, respectively.
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edly, reaching a value at the maximum denaturant concen-
tration significantly lower than that in the absence of
denaturant. This result is notably different from similar
studies on tuna apomyoglobin (Bismuto et al., 1988) and
human superoxide dismutase (Mei et al., 1992). In the
apomyoglobin case the data fit best to a Lorentzian distri-
bution, and the width of this distribution increased dramat-
ically above 0.5 M guanidinium chloride, remaining con-
stant above 2 M denaturant. In the human superoxide
dismutase case there was a significant initial increase in the
width of the distribution, followed by a slight decrease at
higher denaturant concentration, but the width at the highest
denaturant concentration was significantly larger than that
in the absence of denaturant. Our lifetime results on apo-
HRP suggest that either the number of conformational sub-
states available for the tryptophan in the unfolded protein is
less than in native protein or that the dynamics of the
interconversion between substates is enhanced in unfolded
apoHRP. The fact that unfolded apoHRP still has four
disulfide bonds in our denaturation conditions may, in fact,
limit the conformational substates accessible. One may ex-
pect that the ratio of the lifetimes at zero and 0.6 M
guanidinium chloride would match the corresponding ratio
of the intensities. The intensity ratio, however, is 2.45,
whereas the ratio of the long-lifetime components is 3.94/
3.34 1.18. A more appropriate calculation should take the
short component into account. The initial intensity increase,
in fact, can be more reasonably accounted for if the short,
discrete component is converted into the longer, distributed
component as guanidinium chloride is added. Specifically,
if we consider the intensity (I) in the absence of denaturants
to be due to two components, a “long” component (1) and
a “short” component (2), then
I 11 22
where 1 and 2 are preexponential factors. The relation-
ships between the preexponential factors and the fractional
contributions to the steady-state intensities (fi) are given by
1
f11
f11 f22
; 2
f22
f11 f22
In the absence of denaturant, 1  3.34 (using the center
value of the distribution), f1  0.862, 2  0.35, and f2 
0.138, which results in 1  0.40 and 2  0.60. The
normalized intensities at zero and 0.6 M guanidinium chlo-
ride are thus I0  (0.60)(0.35)  (0.40)(3.34)  1.55 and
I0.6M  (0)(0.35)  (1.0)(3.94)  3.94. The ratio of these
calculated intensities is thus 2.54, compared to 2.45, the
ratio of the observed intensities. This calculation is admit-
tedly not strictly correct, because it should be used only for
discrete components, and we are using the center value of a
distribution for one component, but the purpose of the
calculation is to demonstrate the principle involved and to
show that the apparent discrepancy between the observed
intensity and lifetime ratios for zero and 0.6 M denaturant
can be accounted for, in principle, with a simple model.
FIGURE 3 Gaussian distribution curves corresponding to the lifetime
results for apoHRP in 0 M (A), 0.5 M (B), and 7.6 M (C) guanidinium
chloride.
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Furthermore, if the short, discrete component has an
emission maximum blue-shifted with respect to the major
component, the disappearance of this short component cou-
pled with its reappearance as a red-shifted component
would also account for the observed red shift in the emis-
sion spectrum in the 0–0.6 M denaturant range. Similarly,
the initial decrease in the polarization could be due to the
disappearance of this shorter-lived component, which
would be expected to have a higher polarization value as a
consequence of its shorter lifetime. In fact, using the Perrin
equation, the polarization change from 0.282 (at zero dena-
turant) to 0.252 (at 0.6 M denaturant) can be almost quan-
titatively accounted for by the increase in the “average”
lifetime from 2.93 ns (at zero denaturant) to 3.94 ns (at 0.6
M denaturant), assuming that the average rotational relax-
ation time of the protein does not vary over this denaturant
range. This result suggests that mobility of the tryptophan
residue does not change significantly in the 0–0.6 M dena-
turant range.
Smith et al. (1990) pointed out in their studies on recom-
binant HRP that the protein needs an excess of calcium to
stabilize a conformation suitable for accepting the prosthetic
group and that the renaturation of HRP is not a reversible
process. Renaturation of apoHRP, on the other hand, ap-
pears to be reversible and to involve more than two states.
The intensity data show an intermediate state that reaches an
intensity maximum near 0.6 M guanidinium chloride. The
presence of this intermediate state is also apparent in the
denaturation and renaturation curves after the polarization
of the tryptophan residue, as shown in Fig. 2. The attribution
of this intermediate state to a molten globule cannot be
made with certainty, however, especially because the usual
approach of studying ANS binding is precluded in this case,
because ANS binds well to the heme-binding site region
(Vargas et al., 1991).
Our data are generally in agreement with the conclusions
of Pappa and Cass (1993) based on their CD experiments,
i.e., that unfolding of apoHRP occurs through a process with
at least three states, as was suggested by the fact that their
denaturation curve from the backbone CD did not coincide
with that from the aromatic CD. Our CD results (data not
shown) completely support these observations. The lack of
agreement between the backbone and aromatic CD results is
indicative of a change in the tertiary structure followed by a
change in the secondary structure as the guanidinium chlo-
ride concentration is increased. The tryptophan intensity
results of Pappa and Cass (1993), on the other hand, gave no
indication of a three-stage unfolding process but, given their
instrumental settings, i.e., 290-nm excitation and 350-nm
observation (vide supra), the third stage may have been
obscured. Our results, obtained upon excitation at 295 nm
and observation of the total emission intensity, indicate that
the intrinsic tryptophan fluorescence of apoHRP correlates
with the aforementioned CD data. Our lifetime and polar-
ization results also indicate at least three stages in the
unfolding process.
FIGURE 4 Center value (F) and width (f) corre-
sponding to the Gaussian distribution fits for apoHRP as
a function of guanidinium chloride concentration.
Closed symbols refer to the unfolding path, and open
symbols refer to the refolding path. Inset shows the
fractional contribution associated with the short, dis-
crete component (0.35 ns) as a function of guanidinium
chloride concentration.
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An issue related to discussions of apoHRP denaturation is
the effect of hemin or PPIX on stabilization of the protein
matrix. Our previous time-resolved fluorescence studies on
apoHRP-PPIX (Jullian et al., 1989; Vargas et al., 1991;
Brunet and Pulgar, 1993; Brunet et al., 1994) clearly dem-
onstrated that the PPIX moiety is held very rigidly in the
heme-binding site, which contradicts the assumption of
Pappa and Cass (based on polarization data, which were not
presented) that PPIX has “substantial mobility when bound
to the protein” (Pappa and Cass, 1993). Pappa and Cass also
reported that the denaturation profile of apoHRP-PPIX,
followed by tryptophan fluorescence, was very similar to
that of apoHRP and concluded that PPIX in the active site
does not stabilize the protein as well as hemin. Our previous
results, however, demonstrated that PPIX does indeed sta-
bilize the protein matrix as well as hemin (Vargas et al.,
1991).
The application of fluorescence methods to the study of proteins was
initiated by Gregorio Weber. This study of the intrinsic fluorescence of
apohorseradish peroxidase is a continuation of Gregorio Weber’s legacy in
several regards. First, the original study of the fluorescence of heme
proteins, including horseradish peroxidase, was carried out by Weber and
Teale in 1959. Second, all authors of this paper were either personally
trained or strongly influenced by Gregorio Weber. Third, the results
presented in this paper were discussed with Gregorio Weber, who offered
many valuable insights. This paper is dedicated to the memory of Gregorio
Weber, whose contributions to biological fluorescence and protein chem-
istry were both numerous and profound, and whose human qualities had
such a powerful influence on generations of scientists.
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